Complex Movement Disorders in Ataxia with Oculomotor Apraxia Type 1: Beyond the Cerebellar Syndrome
- PMID: 33101765
- PMCID: PMC7546098
- DOI: 10.5334/tohm.557
Complex Movement Disorders in Ataxia with Oculomotor Apraxia Type 1: Beyond the Cerebellar Syndrome
Abstract
Background: Ataxia with oculomotor apraxia (AOA1) is characterized by early-onset progressive cerebellar ataxia with peripheral neuropathy, oculomotor apraxia and hypoalbuminemia and hypercholesterolemia.
Case report: A 23-year-old previously healthy woman presented with slowly-progressive gait impairment since the age of six years. Neurological examination revealed profound areflexia, chorea, generalized dystonia and oculomotor apraxia. Brain MRI revealed mild cerebellar atrophy and needle EMG showed axonal sensorimotor neuropathy. Whole exome sequencing revealed a mutation in the aprataxin gene.
Discussion: AOA1 can present with choreoathetosis mixed with dystonic features, resembling ataxia-telangiectasia. This case is instructive since mixed and complex movement disorders is not very common in AOA1.
Highlights: Ataxia with oculomotor apraxia type 1 (AOA1) is characterized by early-onset ataxia and oculomotor apraxia caused by variants in the APTX gene.Ataxia is usually not the sole movement abnormality in AOA1.Hyperkinetic movement disorders, especially chorea and dystonia, may occur.Mixed and complex movement disorders is not very common in AOA1.Patients with early-onset ataxia associated with mixed movement disorders should also be investigated for AOA1.
Keywords: ataxia; ataxia with oculomotor apraxia; ataxia with oculomotor apraxia type 1; cerebellum; movement disorders.
Copyright: © 2020 The Author(s).
Conflict of interest statement
The authors have no competing interests to declare.
Figures
Similar articles
-
Atypical presentation of ataxia-oculomotor apraxia type 1.Dev Med Child Neurol. 2006 Jun;48(6):529-32. doi: 10.1017/S0012162206001113. Dev Med Child Neurol. 2006. PMID: 16700949
-
A novel mutation of aprataxin associated with ataxia ocular apraxia type 1: phenotypical and genotypical characterization.J Neurol Sci. 2007 Sep 15;260(1-2):219-24. doi: 10.1016/j.jns.2007.05.015. Epub 2007 Jun 18. J Neurol Sci. 2007. PMID: 17572444
-
Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.JAMA Neurol. 2018 Apr 1;75(4):495-502. doi: 10.1001/jamaneurol.2017.4373. JAMA Neurol. 2018. PMID: 29356829 Free PMC article.
-
Ataxia with Oculomotor Apraxia Type 1 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.2002 Jun 11 [updated 2015 Mar 19]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2002 Jun 11 [updated 2015 Mar 19]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301629 Free Books & Documents. Review.
-
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia/ataxia with oculomotor apraxia 1.Adv Exp Med Biol. 2010;685:21-33. doi: 10.1007/978-1-4419-6448-9_3. Adv Exp Med Biol. 2010. PMID: 20687492 Review.
Cited by
-
A Novel Compound Heterozygous Mutation in Aprataxin Causes Slowly Progressive Ataxia without Oculomotor Apraxia.Mov Disord Clin Pract. 2024 Sep;11(9):1156-1159. doi: 10.1002/mdc3.14132. Epub 2024 Jun 16. Mov Disord Clin Pract. 2024. PMID: 38881152 Free PMC article. No abstract available.
-
Ataxia with oculomotor apraxia type 1 associated with mutation in the APTX gene: A case study and literature review.Exp Ther Med. 2022 Oct 5;24(6):709. doi: 10.3892/etm.2022.11645. eCollection 2022 Dec. Exp Ther Med. 2022. PMID: 36382100 Free PMC article.
References
-
- Anheim M, Fleury M, Monga B, et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics. 2010; 11: 1–12. DOI: 10.1007/s10048-009-0196-y - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical